The Melero-Martin laboratory seeks a highly motivated postdoctoral research fellow to contribute to a cardiovascular tissue engineering program focused on building vascular and heart tissue constructs. The successful candidate will focus on engineering vascular networks within cardiac tissue constructs, including the generation and assembly of iPSC-derived vascular cells, development of perfusable microvascular networks, and integration of vasculature into engineered heart tissues.

Axsome Therapeutics has announced the resolution of all remaining patent litigation related to its wake-promoting medicine SUNOSI (solriamfetol), bringing an end to a series of legal disputes with generic drug manufacturers seeking U.S. market entry.

Researchers have identified four promising blood-based metabolites that may help distinguish individuals with latent tuberculosis infection (LTBI) from those without infection, according to a new study published in BIO Integration. The findings provide fresh insights into the metabolic changes associated with latent tuberculosis and could support the development of improved diagnostic approaches in the future.